Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines
- PMID: 28469696
- PMCID: PMC5414162
- DOI: 10.1186/s12981-017-0152-0
Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines
Erratum in
-
Erratum to: Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.AIDS Res Ther. 2017 May 22;14:29. doi: 10.1186/s12981-017-0155-x. eCollection 2017. AIDS Res Ther. 2017. PMID: 28539969 Free PMC article.
Abstract
Background: Immune reconstitution inflammatory syndrome (IRIS) can manifest with initiation or reintroduction of antiretroviral therapy (ART) in persons living with HIV (PLWH). In 2012, updated United States treatment guidelines recommended initiation of ART for all PLWH regardless of CD4 count. The objectives of this study were to quantify hospital usage attributable to IRIS and assess the reasons for hospitalization in PLWH before and after the guideline update.
Methods: Subjects were PLWH between 18-89 years of age who were hospitalized between November 1, 2009 and July 31, 2014. Equivalent time periods before and after updated treatment guidelines were considered, and designated as Time Period 1 and Time Period 2, respectively. IRIS-attributable hospitalizations were identified by ICD9 codes and electronic medical record searches with subsequent review and confirmation. For hospitalizations that were not confirmed as being IRIS-attributable, primary discharge diagnoses were reviewed.
Results: A total of 278 PLWH were hospitalized 521 times throughout the study period. Time Period 1 had 9 PLWH with 12 IRIS-attributable hospitalizations while Time Period 2 had 6 PLWH with 9 IRIS-attributable hospitalizations. A larger proportion of IRIS-attributable hospital days was observed in Time Period 1 compared to Time Period 2 (7.5 vs 4.2%; p < 0.001). Median length of stay for IRIS-attributable hospitalizations was longer than for other diagnoses, particularly during Time Period 1 (12.0 vs 4.0; p = 0.05). The most common causes for hospitalizations in PLWH were non AIDS-defining infection, AIDS-defining malignancy, and gastrointestinal. PLWH who had HIV viral suppression (<200 copies/mL) accounted for 34 and 24% of hospitalizations in Time Periods 1 and 2 respectively.
Conclusions: Hospitalizations for PLWH continue at high rates and IRIS is a significant contributing factor. In our single-center study, there was a lower number of IRIS-attributable hospitalizations and IRIS-attributable hospital days in Time Period 2 compared with Time Period 1. The hospital burden of IRIS may decrease over time as more PLWH are started on ART earlier in the course of infection. This study highlights the continued importance of early diagnosis and linkage to care of those infected with HIV, so that morbidity and costs associated with IRIS continue to decline.
Keywords: AIDS; Acquired immunodeficiency syndrome; HIV; Hospitalization; Human immunodeficiency virus; IRIS; Immune reconstitution inflammatory syndrome; Practice guidelines; United States Dept. of Health and Human Services.
Figures
Similar articles
-
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.Lancet Infect Dis. 2015 Apr;15(4):429-38. doi: 10.1016/S1473-3099(15)70008-3. Epub 2015 Feb 9. Lancet Infect Dis. 2015. PMID: 25672566 Free PMC article.
-
Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand.Southeast Asian J Trop Med Public Health. 2010 Jan;41(1):138-45. Southeast Asian J Trop Med Public Health. 2010. PMID: 20578492
-
Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia.Clin Infect Dis. 2020 Jul 27;71(3):652-660. doi: 10.1093/cid/ciz877. Clin Infect Dis. 2020. PMID: 31504347 Free PMC article.
-
Incidence and Trends in Immune Reconstitution Inflammatory Syndrome Associated With Histoplasma capsulatum Among People Living With Human Immunodeficiency Virus: A 20-Year Case Series and Literature Review.Clin Infect Dis. 2020 Feb 3;70(4):643-652. doi: 10.1093/cid/ciz247. Clin Infect Dis. 2020. PMID: 30921453 Review.
-
Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review.Pediatr Infect Dis J. 2014 May;33(5):499-503. doi: 10.1097/INF.0000000000000142. Pediatr Infect Dis J. 2014. PMID: 24736441 Free PMC article. Review.
Cited by
-
Molecular Diagnostics of Cryptococcus spp. and Immunomics of Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.Diseases. 2024 May 13;12(5):101. doi: 10.3390/diseases12050101. Diseases. 2024. PMID: 38785756 Free PMC article. Review.
-
Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Blood and Cerebrospinal Fluid Biomarkers to Treatment Approaches.Life (Basel). 2021 Jan 27;11(2):95. doi: 10.3390/life11020095. Life (Basel). 2021. PMID: 33514007 Free PMC article. Review.
-
Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region.Clinicoecon Outcomes Res. 2018 Jul 23;10:389-398. doi: 10.2147/CEOR.S162625. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 30087571 Free PMC article.
-
Erratum to: Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.AIDS Res Ther. 2017 May 22;14:29. doi: 10.1186/s12981-017-0155-x. eCollection 2017. AIDS Res Ther. 2017. PMID: 28539969 Free PMC article.
References
-
- Teeraananchai S, Kerr S, Ruxrungtham K. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med [Epub ahead of print]. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
